MedTrace Logo

A Study Measuring Substances Potentially Indicating Bone Problems in Adults With Type 1 Gaucher Condition

NCT05702814 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2024-12-11

No results posted yet for this study

Summary

Substances in the body, so-called biomarkers, can help predict the severity of Gaucher disease (GD)-related bone problems in adults. The main aim of the study is to determine if certain biomarkers found in the body at the time of diagnosing GD can help predict the risk of bone problems after 4-5 years.

There is no treatment involved in this study. The study will review previously collected participants' data using a database. Data from both adults with type 1 Gaucher condition as well as healthy adults will be compared.

Conditions

  • Gaucher Disease

Interventions

OTHER

No Intervention

As this is an observational study, no intervention will be administered.

Sponsors & Collaborators

Principal Investigators

  • Study Director · Takeda

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-27
Primary Completion
2024-05-20
Completion
2024-05-24

Countries

  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05702814 on ClinicalTrials.gov